Journals / Türk Kardiyoloji Derneği Arşivi / 2022 / Cilt: 50 - Sayı: 1

Reversal of metabolic syndrome with weight loss decreases epicardial fat more than weight loss alone in women with obesity

Obez kadınlarda kilo vererek metabolik sendromun düzelmesi yalnızca kilo vermeye kıyasla epikardiyal yağ kalınlığını daha fazla azaltır

Pages
48–56
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Body mass index was significantly reduced from 37.17±5.94 to 31.61±5.55 kg/m2 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to investigate the impact of weight loss with diet and exercise on echocardiographically measured epicardial fat thickness (EFT) in women with obesity and whether the change in EFT can be different between the groups whose metabolic syndrome (MetS) status has changed or remained the same with weight loss.
📊
Key Findings & Data:Methods: Seventy four women with obesity who were scheduled for a one-year weight reduction (WR) program were prospectively enrolled in the study.
💡
Conclusion & Impact:Results: Body mass index was significantly reduced from 37.17±5.94 to 31.61±5.55 kg/m2 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to investigate the impact of weight loss with diet and exercise on echocardiographically measured epicardial fat thickness (EFT) in women with obesity and whether the change in EFT can be different between the groups whose metabolic syndrome (MetS) status has changed or remained the same with weight loss. Methods: Seventy four women with obesity who were scheduled for a one-year weight reduction (WR) program were prospectively enrolled in the study. Anthropometric, laboratory, clinical, and echocardiographic parameters were assessed at baseline and after one year for twenty eight women who completed the program and had weight reduction. At the end of one year, all the participants were divided into two groups on the basis of whether their MetS status had changed or remained the same. Results: Body mass index was significantly reduced from 37.17±5.94 to 31.61±5.55 kg/m2 (p

Özet

Amaç: Çalışmanın amacı obez kadınlarda diyet ve egzersiz ile kilo vermenin ekokardiyografik olarak ölçülen epikardiyal yağ kalınlığı (EYK) üzerine olan etkisini ve EYK’daki değişimin metabolik sendrom (MetS) durumunda değişiklik olan ve olmayan hasta grupları arasında fark gösterip göstermediğini incelemek idi. Yöntemler: Bir yıllık kilo verme programına dahil edilmesi planlanan yetmiş dört obez kadın hasta prospektif olarak çalışmaya dahil edildi. Antropometrik, laboratuvar, klinik ve ekokardiyografik parametreler başlangıçta ve programı tamamlayarak kilo vermeyi başaran yirmi sekiz olgu için 1 yıl sonunda tekrar değerlendirildi. 1 yılın sonunda hastalar MetS durumu değişen ve değişmeyenler olarak iki gruba ayrıldı. Bulgular: Vücut kitle indeksi, 1 yıllık kilo verme programından sonra 37.17±5.94’ten 31.61±5.55 kg/m2’ye (p

🔖

Cite This Article

DEMİRCİ, D. E., DEMİRCİ, D., EKE, R. N. (2022). Reversal of metabolic syndrome with weight loss decreases epicardial fat more than weight loss alone in women with obesity. Türk Kardiyoloji Derneği Arşivi, Cilt: 50 - Sayı: 1, 48–56. https://ajindex.com/articles/631763

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Folsom AR, Kushi LH, Andersen KE, Mink PJ, Olson JE, Hong CP, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med 2000;160:2117-28. [Crossref] 2. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006;368:666-78. [Crossref] 3. Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016;388:776-86. [Crossref] 4. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 2006;14:20-4. [Crossref] 5. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses apathogenic profile ofadipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006;5:1. [Crossref] 6. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304-10. [Crossref] 7. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Mario UD, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304-10. [Crossref] 8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J 2013;34:2159-219. [Crossref] 9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. [Crossref] 10. American Diabetes Association
  2. Classification and diagnosis of diabetes. Diabetes Care 2015;38:8-16. [Crossref] 11. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. NHLBI/AHA Conference Proceedings. Circulation 2004;109